SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Amgen (AMGN)

AMGN RSS Feed
Add AMGN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/31/2017 5:45:49 PM - Followers: 17 - Board type: Free - Posts Today: 0

This board is for fundamental and technical discussion about Amgen, AMGN. Amgen Inc. (Amgen) is a global biotechnology company. It discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation and oncology. In September 2006, Vectibix (panitumumab), Amgen's first oncology therapeutic, received the United States Food and Drug Administration approval and became commercially available in October 2006. The Company's principal products include Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim), NEUPOGEN (Filgrastim), EPOGEN (Epoetin alfa) and Enbrel (etanercept). On April 1, 2006, Amgen acquired Vectibix as part of its acquisition of Abgenix, Inc. On October 24, 2006, it acquired Avidia, Inc., which discovered and developed a class of human therapeutic known as Avimer proteins. In July 2007, it acquired Alantos and Ilypsa. Share Price: $40.11 3/20/2008 52 Week High: $69.11 52 Week Low: $39.16 EPS: $2.82 P/E Ratio: 14.22 Outstanding Shares: 1.09 Billion AMGEN INC 1 Amgen Center Dr Thousand Oaks, CA 91320-1799 USA Phone: 805-447-1000 Fax: 805-447-1010 http://www.amgen.com Daily One-Year Charts Weekly Five-Year Charts
AMGN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMGN News: Amgen And Humana Partner For Improved Health Outcomes And Efficiency 08/17/2017 04:00:00 PM
AMGN News: Repatha® (Evolocumab) Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine 08/16/2017 05:10:00 PM
AMGN News: Confidential Treatment Order (ct Order) 08/15/2017 09:28:56 AM
AMGN News: Scottish Medicines Consortium Accepts Amgen's Multiple Myeloma Treatment, KYPROLIS® ? (carfilzomib), in Combination with D... 08/08/2017 02:00:00 AM
AMGN News: Statement of Changes in Beneficial Ownership (4) 08/04/2017 05:51:59 PM
PostSubject
#396   https://seekingalpha.com/article/4092782-amgen-looks-enhance-cholesterol-drug Inoviorulez 07/31/17 05:45:49 PM
#395   AMGN 2Q17 CC slides: DewDiligence 07/25/17 04:39:58 PM
#394   https://seekingalpha.com/article/4089618-amgen-novartis-first-mover-advantage-mu Inoviorulez 07/23/17 02:28:01 AM
#393   https://seekingalpha.com/article/4088415-amgen-receives-crl-osteoporosis-drug-ne Inoviorulez 07/18/17 11:43:44 AM
#392   https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto Inoviorulez 07/13/17 09:18:10 AM
#391   The ins and outs of the Amgen v HONEYDEG 06/13/17 12:25:34 PM
#390   The ins and outs of the Amgen v HONEYDEG 06/13/17 12:25:29 PM
#389   http://news.sky.com/story/ovarian-cancer-drug-hailed-as-biggest-breakthrough-in- sci101 06/03/17 01:48:00 PM
#388   Confidential Treatment Order (ct Order) TREND1 05/30/17 03:55:49 PM
#387   DEW here is exact post TREND1 05/30/17 03:37:38 PM
#386   SEE MNKD BOARD TREND1 05/30/17 03:35:10 PM
#385   First I've heard of that notion. Where did DewDiligence 05/30/17 03:32:35 PM
#384   Dew Do you see AMGN taking over MNKD ? TREND1 05/30/17 03:31:34 PM
#383   FLOAT= 735.16M TREND1 05/30/17 03:24:18 PM
#382   PE = 15.1 TREND1 05/30/17 03:22:41 PM
#381   EPS = 10.32 TREND1 05/30/17 03:21:40 PM
#380   AMGN TREND1 05/30/17 03:17:29 PM
#379   AMGN offers “money-back” pricing on Repatha for US DewDiligence 03/18/17 11:27:10 AM
#378   The Appellate Court stayed the decision pending appeal, DewDiligence 02/12/17 06:04:40 PM
#377   Regeneron Pharmaceuticals And Sanofi Loses On A Suit trendmkr 02/09/17 02:07:28 PM
#376   5yr DCF imply Amgen Inc $AMGN is 20% ValueInvestor15 02/01/17 10:30:31 AM
#375   FDA approves AMGN’s Humira biosimilar: DewDiligence 09/23/16 07:13:48 PM
#374   AMGN---GLTA! Dadx4 09/15/16 09:57:54 AM
#373   AMGN romanov5 09/07/16 12:09:28 PM
#372   AMGN/AGN report phase-3 data for Herceptin FoB: #msg-124404733. DewDiligence 08/09/16 10:43:03 AM
#371   It's a small risk for AMGN, since the DewDiligence 08/02/16 06:26:03 PM
#370   Any thoughts on the Advaxis deal? gccarlin99 08/02/16 06:21:25 PM
#369   AMGN DAY TREND1 07/28/16 01:09:17 PM
#368   AMGN DAY TREND1 07/25/16 03:08:51 PM
#367   Short % of Float = 1.19% TREND1 07/25/16 02:42:35 PM
#366   Inst % Owned = 88% TREND1 07/25/16 02:26:16 PM
#365   EPS = 9.15 TREND1 07/25/16 02:24:56 PM
#364   AMGN DAY TREND1 07/23/16 12:22:25 PM
#363   AMGN bullish 163.03 stocktrademan 07/21/16 02:13:23 PM
#362   This Bounce Has Serious Legs: $AMGN ITMS 06/28/16 12:11:37 PM
#361   The Big Short's Dr. Michael Burry goes long 0dd Lot 05/23/16 08:42:00 PM
#360   $AMGN Daily and Weekly Charts http://www.stock $Pistol Pete$ 02/18/16 09:28:01 PM
#359   Who Would Make a Good Suitor for Shield nyctraydr 02/15/16 11:57:25 AM
#358   $AMGN Daily Chart http://www.stockcharts.com/c $Pistol Pete$ 02/14/16 05:21:11 PM
#357   Dermira Targets a Billion Dollar Opportunity -article mentions venturecapp 01/22/16 11:10:33 AM
#356   Is Guardant Next in Line for a Big trendmkr 01/08/16 11:57:24 AM
#355   Amgen is Targeting a Blockbuster SOC Upheaval in trendmkr 01/07/16 01:00:55 PM
#354   Good news for us: http://finance.yahoo.com/news/analysts-latest-recommendations- investorsa 12/29/15 09:15:05 AM
#353   thanx Dewwy Fibanotch 12/01/15 01:48:18 PM
#352   I’ve heard suggestions that AMGN might consider spinning DewDiligence 12/01/15 11:59:44 AM
#351   Do u care to elaborate on either? Fibanotch 12/01/15 11:41:16 AM
#350   Are you asking about a split-up of AMGN DewDiligence 11/30/15 07:11:35 PM
#349   u think this thing will split , in Fibanotch 11/30/15 05:55:37 PM
#348   FDA reviewing NVS’ 351(k) submission for Neulasta FoB: #msg-118583523. DewDiligence 11/18/15 10:19:21 AM
#347   Musings on Humira’s patent estate: #msg-118144295. DewDiligence 10/31/15 12:17:10 PM
PostSubject